(Q38175483)

30 August 2017

Current gene therapy trials for vascular diseases (English)

1 reference

30 August 2017

0 references

4

1 reference

30 August 2017

3

Antti Kuivanen

1 reference

30 August 2017

2

Jussi Nurro

1 reference

30 August 2017

Paavo J Halonen

1

1 reference

PubMed ID

24387602

30 August 2017

language of work or name

English

0 references

publication date

3 January 2014

1 reference

Expert Opinion on Biological Therapy

30 August 2017

1 reference

30 August 2017

14

1 reference

30 August 2017

3

1 reference

30 August 2017

327-336

1 reference

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

30 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.872237

Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.872237

Cardiovascular gene therapy with vascular endothelial growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.872237

Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.872237

Therapeutic angiogenesis for revascularization in peripheral artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.872237

VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.872237

Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.872237

10-year safety follow-up in patients with local VEGF gene transfer to ischemic lower limb

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.872237

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.872237

Gene therapy clinical trials worldwide to 2012 - an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.872237

US gene therapy in crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.872237

Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.872237

Lessons learned from the clinical development and market authorization of Glybera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.872237

A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.872237

Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.872237

Safety of direct cardiac administration of AdVEGF-All6A+, a replication-deficient adenovirus vector cDNA/genomic hybrid expressing all three major isoforms of human vascular endothelial growth factor, to the ischemic myocardium of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.872237

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.872237

Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.872237

Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.872237

Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.872237

Percutaneous approaches for efficient cardiac gene delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.872237

AAV vectors for cardiac gene transfer: experimental tools and clinical opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.872237

10.1517/14712598.2014.872237

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference

PubMed ID

24387602